aap Implantate - Public Comps and Valuation Multiples

aap Implantate Overview

About aap Implantate

aap Implantate AG develops, manufactures, and markets trauma products for orthopedics. The company classifies its products that are Trauma and Others. The product line of the company consists of a plating system under the brand LOQTEQ, and cannulated screws. The company's projects such as antibacterial silver coating technology and magnesium-based implants. It develops a plating system for the Shoulder, Knee, Elbow, Wrist, and Ankle Joint. The company sells its product directly to hospitals, syndicates, and hospital groups with the help of distributors.

Founded

1997

HQ

Employees

109

Website

aap.de

Sectors

Medical Devices
HealthTech

Financials

LTM Revenue n/a

LTM EBITDA n/a

EV

$25.4M

Valuation Multiples

Multiples.vc

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

aap Implantate Financials

aap Implantate has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.

In the most recent fiscal year, aap Implantate achieved revenue of $12.3M and an EBITDA of -$3.7M.

aap Implantate expects next 12-month revenue of XXX and NTM EBITDA of XXX

See aap Implantate valuation multiples based on analyst estimates

aap Implantate P&L

	FY 2023	FY 2024	FY 2025	LTM	NTM
Revenue	$12.3M	n/a	XXX	XXX	XXX
Gross Profit	$11.7M	$11.4M	XXX	XXX	XXX
Gross Margin	95%	NaN%	XXX	XXX	XXX
EBITDA	-$3.7M	n/a	XXX	XXX	XXX
EBITDA Margin	-30%	NaN%	XXX	XXX	XXX
Net Profit	-$2.9M	-$2.9M	XXX	XXX	XXX
Net Margin	-24%	NaN%	XXX	XXX	XXX
Net Debt	$0.3M	$0.3M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

aap Implantate Stock Performance

As of April 15, 2025, aap Implantate's stock price is EUR 1 (or $2).

aap Implantate has current market cap of EUR 20.0M (or $21.5M), and EV of EUR 23.7M (or $25.4M).

See aap Implantate trading valuation data

aap Implantate Stock Data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$25.4M	$21.5M	XXX	XXX	XXX	XXX	n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

aap Implantate Valuation Multiples

As of April 15, 2025, aap Implantate has market cap of $21.5M and EV of $25.4M.

aap Implantate's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate aap Implantate's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See valuation multiples for aap Implantate and 10K+ public comps

aap Implantate Financial Valuation Multiples

	FY 2024	FY 2025E	FY 2026E	FY 2027E
EV	$25.4M	XXX	XXX	XXX
EV/Revenue	n/a	XXX	XXX	XXX
EV/EBITDA	n/a	XXX	XXX	XXX
P/E	n/a	XXX	XXX	XXX
P/E/Growth	n/a	XXX	XXX	XXX
EV/FCF	n/a	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get aap Implantate Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

aap Implantate Valuation Multiples

aap Implantate's NTM/LTM revenue growth is n/a

aap Implantate's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.1M for the same period.

Over next 12 months, aap Implantate's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .

Analysts estimate aap Implantate's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See operational valuation multiples for aap Implantate and other 10K+ public comps

aap Implantate Operational Valuation Multiples

	FY 2024	NTM	FY 2025E	FY 2026E	FY 2027E
Revenue Growth	n/a	XXX	XXX	XXX	XXX
EBITDA Margin	n/a	XXX	XXX	XXX	XXX
EBITDA Growth	n/a	XXX	XXX	XXX	XXX
Rule of 40 (SaaS-only)	n/a	XXX	XXX	XXX	XXX
Revenue per Employee	$0.1M	XXX	XXX	XXX	XXX
Opex per Employee	$0.1M	XXX	XXX	XXX	XXX
S&M Expenses to Revenue	18%	XXX	XXX	XXX	XXX
G&A Expenses to Revenue	23%	XXX	XXX	XXX	XXX
R&D Expenses to Revenue	2%	XXX	XXX	XXX	XXX
Opex to Revenue	130%	XXX	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry